$RDNT

SWARTZ DAVID L sold $145K of RDNT

SWARTZ DAVID L sold 2,699 shares of RadNet, Inc. (RDNT) at $53.89 ($0.15M total) on 2026-06-18.

Original reporting
SEC EDGAR · SWARTZ DAVID L
Published Jun 22, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 22, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RDNT
Neutral
high confidence
Mentioned
$RDNT
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RDNTNeutralLow
01

Why it matters

The newest fact is the specific open-market sale (2,699 shares at $53.89) disclosed on 2026-06-22; it may slightly affect sentiment but does not change the company’s fundamentals in the text.

02

Market read

Traders may log the sale for sentiment/positioning monitoring, but there is no new earnings, guidance, deal, or regulatory development here.

03

What to watch

The article notes no 10b5-1 plan; however, it still lacks intent details, and the sale size may be driven by diversification/taxes rather than fundamentals.

Relevance 4/10Novelty 5/10Timing: after-hours/filing update (Form 4 filed 2026-06-22)

Background

The article is an SEC Form 4 insider transaction for RadNet, Inc. (RDNT) by director David L. Swartz.

Company-level read

Ticker impact

$RDNTNeutralHigh confidence
Context

RadNet director David L. Swartz filed a Form 4 selling 2,699 shares at $53.89 on 2026-06-18, totaling $145,449.11.

Expected impact

Likely minimal near-term impact; any effect is typically short-lived unless accompanied by unusual follow-on selling or other disclosures.

Evidence & confidence

The filing is a disclosed sale (not a buy), small relative to company size, and provides no new operational/regulatory/financial information—so tradable impact is usually limited.

Market effects

No sector-level read-across; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can sometimes precede broader selling or reflect negative private information, so traders may watch for follow-on Form 4 activity or changes in trading patterns.

Key entities

  • RadNet, Inc.

    Company whose director insider sale is disclosed via Form 4.

  • David L. Swartz

    Director who sold 2,699 shares in an open-market transaction.

Related articles

$RDNTMed

DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite

DeepHealth, a RadNet subsidiary (NASDAQ: RDNT), said it received two FDA 510(k) clearances for its Breast Suite: Breast Arterial Calcification (BAC) Assessment and prior-exam integration into ProFound Pro, to be marketed as Mammo Dx. Both are now commercially available in the U.S. DeepHealth reported BAC performance of >90% sensitivity and >88% specificity.